University of Northern Colorado

Scholarship & Creative Works @ Digital UNC
Dissertations

Student Research

8-2020

Effects of Exercise on Myeloid-Derived Suppressor Cell-Related
Tumor Progression and Metastasis
Jacob Garritson

Follow this and additional works at: https://digscholarship.unco.edu/dissertations

Recommended Citation
Garritson, Jacob, "Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor Progression and
Metastasis" (2020). Dissertations. 707.
https://digscholarship.unco.edu/dissertations/707

This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @
Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship &
Creative Works @ Digital UNC. For more information, please contact Jane.Monson@unco.edu.

© 2020
Jacob Garritson
ALL RIGHTS RESERVED

UNIVERSITY OF NORTHERN COLORADO
Greeley, Colorado
The Graduate School

EFFECTS OF EXERCISE ON MYELOID-DERIVED
SUPPRESSOR CELL-RELATED TUMOR
PROGRESSION AND METASTASIS

A Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy

Jacob Garritson

College of Natural and Health Sciences
School of Sport and Exercise Science
Exercise Physiology
August 2020

This Dissertation by: Jacob Garritson
Entitled: Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor
Progression and Metastasis
has been approved as meeting the requirement for the Degree of Doctor of Philosophy in
College of Natural and Health Sciences in School or Department of Sport and Exercise
Science, Program of Exercise Physiology

Accepted by the Doctoral Committee

____________________________________________________
Reid Hayward Ph.D., Research Advisor

____________________________________________________
David Hydock Ph.D., Committee Member

____________________________________________________
James Haughian Ph.D., Committee Member

____________________________________________________
Nicholas Pullen Ph.D., Faculty Representative

Date of Dissertation Defense: June 10, 2020

Accepted by the Graduate School

______________________________________________________________
Cindy Wesley, Ph.D.
Interim Associate Provost and Dean
The Graduate School
Research Projects and Sponsored Programs

ABSTRACT
Garritson, Jacob. Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor
Progression and Metastasis. Published Doctoral Dissertation, University of
Northern Colorado, 2020.

Myeloid-derived suppressor cells (MDSCs) are potent suppressors of immune
function and may play a key role in the development and progression of metastatic
cancers. Aerobic exercise has been shown to have anticancer effects, yet the mechanisms
behind this protection are largely unknown. Purpose: to determine the effects of physical
activity on MDSC accumulation and function. Methods: Female BALB/c mice were
assigned to one of two primary groups: sedentary tumor (SED+TUM) or wheel run tumor
(WR+TUM). After 6 weeks of voluntary wheel running, all animals were randomly
subdivided into 4 different timepoint groups; 16, 20, 24, and 28 days post-tumor cell
injection. All mice were inoculated with 4T1 mammary carcinoma cells in the mammary
fat pad and WR groups continued to run for the specified time post-injection. Spleen,
blood, and tumor samples were analyzed using flow cytometry to assess proportions of
MDSCs (CD11b/Ly6G/Ly6C). MDSCs were purified from the spleen to assess T-cell
suppressive capacity and metastatic lesions were quantified in the lung. Results
Compared to SED+TUM, levels of MDSCs in the spleen were significantly lower (p <
0.05) in WR+TUM at day 16 (33 ± 5%; 23 ± 10% of total cells, respectively) and day 20
(34 ± 8%; 24 ± 5% of total cells, respectively). Additionally, there were significantly
fewer circulating MDSCs (p < 0.05) in WR+TUM at day 16 and there was a non-
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significant (p = 0.08) trend toward lower MDSCs at day 28 in the tumors of WR+TUM.
While this delay in MDSC accumulation did not translate to a decrease in tumor growth,
physical activity led to 62% and 26% fewer metastatic lung nodules at days 24 and 28,
respectively. At day 28, MDSCs harvested from SED+TUM significantly suppressed
CD3+CD4+ T-cell proliferation (3.2 ± 1.3 proliferation index) while T-cell proliferation in
WR+TUM MDSC co-cultures (5.1 ± 1.7 proliferation index) was not different from
controls. Conclusions: These findings suggest that physical activity may delay the
accumulation of immunosuppressive MDSCs providing a broader window of opportunity
for early interventions with increasingly common immunotherapies.

iv

ACKNOWLEDGEMENTS
This dissertation could not have been possible without the many supportive and
caring individuals that helped me during this process. I would like to acknowledge those
who selflessly aided me in completing this project.
I would like to thank my advisor and mentor, Dr. Reid Hayward. Thank you for
everything you have done for me during my time at UNC. Your influence in my life
extends well beyond our professional relationship, and I can only hope to emulate what I
have learned from you both academically and personally. I will be forever grateful for the
time that I was able to work with you.
To Dr. David Hydock, while I did not have the pleasure of collaborating very
heavily on projects with you during my time at UNC, your general approach to being a
successful academic and teacher is something I will always appreciate. Your enthusiasm
for you students and research encouraged me to be the best teacher and lab mentor that I
could during my time as a teaching assistant – which I quickly came to realize is not as
easy as you make it look.
Dr. James Haughian, your general enthusiasm and love for what you do was the
initial spark for my interest in understanding cancer biology. Your ability to think
critically about complex biological questions inspired me to think more outside-the-box
when it came to approaching a research problem.

v

Thank you, Dr. Nicholas Pullen, for your guidance and assistance troubleshooting
many of the techniques I used for this project. Your passion for academics has been
inspiring (and somewhat intimidating). Also, your humor and encouragement helped
keep me motivated during difficult times. Thank you for all the time you spend to help
not only me, but the countless other graduate and undergraduate students you mentor.
Special thanks to Ms. Lea Haverbeck, Mr. Luke Krynski, Ms. Viva Rase, and all
other graduate and undergraduate students who either assisted with this project or other
aspects of my UNC career. Your help managing animals, collecting data, and general
presence in the lab made the time pass much more quickly. I am happy to have crossed
paths with all of you and I look forward to seeing what you do in your future careers!

vi

TABLE OF CONTENTS
CHAPTER
I.

INTRODUCTION ………………………………………………………...... 1
Statement of Purpose
Research Hypotheses

II.

REVIEW OF LITERATURE ………………………………………………. 6
Tumor Model
Myeloid-Derived Suppressor Cells
Aerobic Exercise and Cancer
Summary

III.

METHODS ………………………………………………………………... 22
Experimental Design
Animals and Animal Care
Cell Culture, Tumor Inoculation, and Measurement
Exercise Training Protocol
Flow Cytometry
T-cell Suppression Assay
Validation of Lung Metastasis

IV.

RESULTS …………………………………………………………………. 31
General Observations
Myeloid-Derived Suppressor Cell Accumulation and Tumor Progression
T-cell Suppression Assay

V.

DISCUSSION AND CONCLUSIONS ……………………………………. 40
Conclusions
Limitations

REFERENCES ……………………………………………………………………….. 47
APPENDIX A – Pilot Data ………………................................................................... 69
APPENDIX B – Myeloid-Derived Suppressor Cell Gating Strategy ………………... 73
APPENDIX C - Institutional Animal Care and Use Committee
Protocol Approval ………………………………………………….. 76
vii

LIST OF TABLES
TABLE
1

Abbreviations ....................................................................................................

viii

5

LIST OF FIGURES
FIGURE
1

Experimental design .......................................................................................

23

2

T-cell suppression assay design .....................................................................

28

3

Detection of cell division by dye dilution ......................................................

29

4

Body mass ......................................................................................................

32

5

Running distance in WR+TUM animals ........................................................ 33

6

MDSC accumulation ......................................................................................

35

7

Tumor mass ....................................................................................................

36

8

Metastatic lung nodules .................................................................................. 36

9

Spleen mass ....................................................................................................

37

10

Gating strategy for MDSC purification using FACS .....................................

38

11

T-cell suppression assay in MDSC co-cultures .............................................

39

12

4T1-dependent MDSC production .................................................................

70

13

Early MDSCs .................................................................................................

72

14

Myeloid-derived suppressor cell gating strategy ...........................................

75

ix

CHAPTER I
INTRODUCTION
Recent reports from the American Cancer Society project that more than 1.7
million new cancer cases will occur in 2019, and over 600,000 people will die from
cancer this year. In general, incidence rates for all types of cancer have decreased from
2009-2015. This is potentially credited to a sharp decline in colorectal cancers (CRC) in
men over the past 5 years as overall cancer incidence rates in women have remained
relatively stable for the past few decades (Siegel, Miller, & Jemal, 2019). For example,
female breast cancer incidence increased by 0.4% from 2004-2015, which has been partly
attributed to the obesity epidemic (Cronin et al., 2018). Consequently, a significant
number of people are living with cancer, which is the second leading cause of death in
the United States (Heron & Anderson, 2016).
Epidemiological data support an association between physical activity and a
decrease in cancer risk and mortality. This is important to consider due to the worldwide
increase in physically inactive individuals. It is estimated that 31% of adults are
physically inactive worldwide and this number continues to rise each year (Hallal et al.,
2012). Fortunately, regular physical activity (PA) can reduce the risk for developing
cancer. Specifically, meeting the current recommendation of 150 min/week of moderatevigorous PA (MVPA) may result in a 12% reduction in the risk for developing breast
cancer (Liu et al., 2016). Several mechanisms behind the protective effect of PA on
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cancer risk and mortality have been proposed, including a reduction in sex hormones,
insulin levels, and chronic low grade inflammation (Dethlefsen, Pedersen, & Hojman,
2017). Additionally, exercise has the potential to influence the balance between proinflammatory and anti-inflammatory signals, as well as the recruitment and function of
myeloid and lymphoid lineage immune cells. This relationship is of particular interest,
especially in the context of cancer and cancer therapy.
Myeloid-derived suppressor cells (MDSCs) have garnered significant interest
among cancer researchers in recent years. As the name suggests, MDSCs are immune
cells of myeloid origin with the ability to suppress both innate and adaptive immune
responses. Also, MDSCs have been implicated as contributors in the development of
metastatic disease. MDSC induction is a result of overproduction of tumor-produced
growth factors and pro-inflammatory signals. For example, granulocyte-macrophage
colony-stimulating factor (GM-CSF) has been shown to generate MDSCs with potent
immune suppressive function (Morales, Kmieciak, Knutson, Bear, & Manjili, 2010;
Serafini et al., 2004). Additionally, interleukin-6 (IL-6) and interleukin-1β (IL-1β) are
two pro-inflammatory cytokines that are important for the accumulation and suppressive
function of MDSCs (Bunt et al., 2007; Zhang et al., 2018). Chronic inflammation is one
of the hallmarks of cancer and the resulting generation of immune suppressive MDSCs
supports the hypothesis that inflammation drives tumor progression and metastasis by
suppressing antitumor immune responses. MDSCs also play a role in the failure of
modern immunotherapies. For instance, melanoma patients with low levels of circulating
MDSCs had an improved response to ipilimumab treatment (Schilling et al., 2016).
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Therefore, targeting MDSCs is a logical approach to improve the outcomes of patients
receiving immunotherapy.
Exercise has been shown to have antitumor effects and one potential mechanism
explaining this is a reduction in chronic low-grade inflammation, or perhaps even more
important, is an acute increase in anti-inflammatory cytokines. IL-6 has been studied
extensively and has traditionally been thought of as a pro-inflammatory cytokine.
However, depending on the context, IL-6 may also stimulate anti-inflammatory signals.
Specifically, increases in muscle-derived IL-6 during exercise leads to an increase in the
anti-inflammatory cytokines interleukin 10 (IL-10) and interleukin 1 receptor antagonist
(IL-1ra) (Steensberg et al., 2003). It has been suggested that chronic exercise may
decrease systemic levels of pro-inflammatory mediators such as c-reactive protein (CRP),
tumor necrosis factor α (TNF-α), and IL-6, but the reductions are modest at best (Shaw et
al., 2015; Thomas et al., 2012). As such, a regular accumulation of acute bouts of aerobic
exercise that result in consistent increases in systemic anti-inflammatory cytokines may
be more important when it comes to the antitumor effects of exercise. Further, acute
exercise can improve antitumor immunity by mobilizing highly cytotoxic natural killer
(NK) cells to the tumor microenvironment in an epinephrine and IL-6 dependent manner
(Pedersen et al., 2016). In order to facilitate antitumor immunity by cytotoxic immune
cells, it will also be important to consider how exercise affects intratumoral immune
suppression.
For cancer patients receiving immunotherapy, it is imperative to elucidate
methods that may reduce MDSC-related immune suppression. To date, no studies have
investigated the effects of exercise on the accumulation and function of MDSCs.
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Considering recent increases in the use of immunotherapies and a growing population of
individuals living with cancer, it is imperative to answer questions surrounding the role
exercise may play in modulating MDSCs.
Statement of Purpose
The purpose of this study was threefold: (a) to examine the effects of endurance
exercise training on the time course of MDSC accumulation in a mouse tumor-bearing
model, (b) to examine the effects of exercise on the suppressive quality of MDSCs in a
mouse tumor-bearing model, and (c) examine the effects of exercise on lung metastasis in
a mouse tumor-bearing model.
Research Hypotheses
H1

Endurance exercise training will delay the onset of MDSC accumulation
in the spleen, blood, and tumor of tumor-bearing mice.

H2

MDSCs harvested from exercised mice will have reduced suppressive
quality.

H3

Endurance exercise training will decrease the number of metastatic lesions
in the lungs of tumor-bearing mice.
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Table 1 Abbreviations.
Akt – protein kinase B

NS – natural suppressor

Arg1 – arginase 1

PA – physical activity

CRC - colorectal cancer

TCR – T-cell receptor

CRP - c-reactive protein

TGF-β – transforming growth factor β

ECM – extracellular matrix

TME – tumor microenvironment

EGF – epidermal growth factor

TNF-α - tumor necrosis factor α

EMT – epithelial mesenchymal transition

ROS – reactive oxygen species

FACS – fluorescence activated cell sorting

VEGF – vascular endothelial growth

GM-CSF - granulocyte-macrophage colony-

factor

stimulating factor
HGF – hepatocyte growth factor
HIF-1α – hypoxia inducible factor-1α
HMGB-1 – high mobility group protein 1
IL-10 - interleukin 10
IL-1β - interleukin-1β

IL-1R - IL-1 receptor
IL-1ra - interleukin 1 receptor antagonist
IL-6 - interleukin-6
MDSC – Myeloid-Derived Suppressor Cell
MVPA – moderate-vigorous physical activity
NK – natural killer cell
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CHAPTER II
REVIEW OF LITERATURE
Recent reports from the American Cancer Society project that more than 1.7
million new cancer cases will occur in 2019 and over 600,000 people will die from
cancer this year. Breast cancer incidence has remained relatively unchanged over the last
decade and the obesity epidemic is one explanation for this observation (Cronin et al.,
2018; Heron & Anderson, 2016). Significant epidemiological data suggest there is a
relationship between physical activity and reductions in cancer risk and mortality. For
example, meeting the recommended 150 min/week of MVPA may reduce the risk for
developing breast cancer by as much as 12% suggesting that breast cancer can be
preventable with a change in lifestyle (Liu et al., 2016). MDSCs are a population of
immune cells that expand in cancer patients and promote tumor progression through the
suppression of antitumor immunity. Exercise has been shown to slow the progression of
solid tumors in various pre-clinical animal models (Betof et al., 2015; Goh, Endicott, &
Ladiges, 2014; Pedersen et al., 2016). Additionally, exercise can modulate the tumor
microenvironment in a manner that facilitates invasion of cytotoxic immune cells and
cancer therapies (Betof et al., 2015; Pedersen et al., 2016), however, its effects on
MDSC-related intratumoral immune suppression have not been investigated.
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Tumor Model
The 4T1 mammary carcinoma is a transplantable tumor cell line that was
originally isolated in 1978. Four morphologically and karyotypically distinct sublines
were isolated from a spontaneously arising mammary tumor in BALB/c mice (Dexter et
al., 1978). All four sublines were shown to be tumorigenic in vivo and the 4T1 cell line
was chosen for its selective resistance to thioguanine (Aslakson & Miller, 1992). Human
breast cancers frequently present with mutations to the p53 tumor suppressor gene
(Bertheau et al., 2013). The p53 protein is a potent regulator of the cell cycle and its
modification and/or deletion results in uncontrolled cell growth. 4T1 cells have been
described as p53 null (Yang et al., 2017; Yerlikaya, Okur, & Ulukaya, 2012) and also
have constitutively active protein kinase B (Akt) (Xue et al., 2012), another common
mutation frequently observed in human breast cancer.
Regarding the experimental advantages of the 4T1 cell line, this cell line closely
resembles the progression of human breast cancer as it is one of the few animal models of
breast cancer that can spontaneously metastasize from the mammary fat pad (Aslakson &
Miller, 1992; Pulaski & Ostrand-Rosenberg, 1998). The progression and metastatic
pattern of 4T1 tumors closely resembles that of human breast cancer with a particular
tropism for the lungs and liver (Pulaski & Ostrand-Rosenberg, 1998). Also, primary 4T1
tumors can be easily established in the mammary gland of female BALB/c mice. Further,
primary tumors can be surgically removed in order to study metastasis in an animal
model that is similar to clinical models where primary tumors have been surgically
removed (Pulaski & Ostrand-Rosenberg, 2001). Thioguanine resistance allows for the
quantification of metastatic nodules in distant organs, which has traditionally been
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difficult experimentally. Organs from 4T1 tumor bearing mice can be harvested and
cultured at specific time points, then treated with thioguanine, leaving only the metastatic
drug resistant 4T1 colonies which can be fixed and quantified (Aslakson & Miller, 1992;
Pulaski & Ostrand-Rosenberg, 1998; Pulaski & Ostrand-Rosenberg, 2001).
The 4T1 tumor model has been used extensively to study the response of triple
negative breast cancers to chemotherapy (Dalezis et al., 2017; Hu et al., 2017; Liu et al.,
2018) and immunotherapy (Du et al., 2017; Finke et al., 2011; Gebremeskel et al., 2017;
Le et al., 2009; Ling et al., 2017; Liu et al., 2018; Noman et al., 2014). Moreover, 4T1
tumors are known to stimulate production of MDSCs, which has made it a popular preclinical model to study the role of intratumoral immune suppression on tumor progression
and metastasis (Bunt, Sinha, Clements, Leips, & Ostrand-Rosenberg, 2006; Bunt et al.,
2007; Finke et al., 2011; Noman et al., 2014; Zhang et al., 2018).
4T1 Tumors and Myeloid-Derived
Suppressor Cells
4T1 tumors secrete many pro-inflammatory signals and chemokines that result in
emergency myelopoiesis and the generation of MDSCs. In recent years the 4T1 tumor
model has been one of the most common animal models used to study MDSC biology.
Bunt and colleagues (2007) investigated the effects of chronic inflammation on MDSC
accumulation and tumor progression (Bunt et al., 2007). 4T1 tumors were implanted into
IL-1 receptor (IL-1R)-deficient mice, which have lower potential for inflammation, and
IL-1ra-deficient mice, which have increased potential for inflammation. MDSC
accumulation was significantly delayed in IL-1R-deficient mice which resulted in
reduced tumor progression compared to IL-1ra-deficient mice. Additionally, IL-6
partially restored MDSCs and tumor progression in IL-1R-deficient mice. These data
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suggest that chronic inflammatory signaling from IL-1β and IL-6 is one of the driving
forces behind the accumulation of MDSCs.
Chronic inflammation, which is common among many cancers, has also been
shown to promote survival of MDSCs. One study used proteomic analysis to identify
proteins expressed in the highly inflammatory 4T1 tumor environment (Chornoguz et al.,
2011). They found that the Fas pathway and caspase proteins were likely candidates that
could explain resistance to apoptosis in MDSCs. Inflammation-induced MDSCs showed
significantly lower levels of activated caspases following treatment with a Fas agonist
suggesting that an inflammatory environment protects MDSCs from extrinsic apoptosis
signals and results in increased half-life of MDSCs. Taken together, these results support
the hypothesis that inflammation is a driving force for the accumulation and survival of
MDSCs, which promote 4T1 tumor progression through the suppression of antitumor
immunity.
Myeloid-Derived Suppressor Cells
MDSCs are most frequently described as a heterogeneous population of immature
immune cells that suppress innate and adaptive immune responses. These cells were
originally discovered in the 1970’s and described as natural suppressor (NS) cells
(Bennett, Srinivasa Rao, & Mitchell, 1978). In mice, two subtypes of MDSCs have been
identified; monocytic MDSCs (M-MDSC) and polymorphonuclear MDSCs (PMNMDSC). M-MDSCs are defined as CD11b+Ly6G–Ly6Chi and PMN-MDSCs are defined
as CD11b+Ly6G+Ly6Clo (Youn et al., 2008). The phenotypic profile of these cells was,
and still is, contentious due to the heterogeneity of these cells and the common markers
shared among other immune cell types such as neutrophils (Talmadge & Gabrilovich,
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2013). Nonetheless, there has been increasing interest in immunosuppressive cells of
myeloid origin due to their role in tumor progression. Due to the lack of well-defined
nomenclature, Gabrilovich and colleagues (2007) suggested that these cells be called
“myeloid-derived suppressor cells” to reflect their origin and function and facilitate
further scientific discussion and progress (Gabrilovich et al., 2007). Although some still
debate the phenotype of these cells, it is now accepted that suppressive cells of myeloid
origin play a critical role in the progression of cancer.
Myeloid-Derived Suppressor Cells:
Generation and Accumulation
Chronic inflammation is one of the hallmarks of cancer and it is now well
established that tumor-produced inflammatory signals promote the accumulation of
MDSCs with potent suppressive activity. For example, high levels of GM-CSF, which is
a common chemokine expressed in 4T1 tumors (Finke et al., 2011), has been shown to
stimulate production of MDSCs that inhibit antigen-specific T-cell responses (Morales et
al., 2010; Serafini et al., 2004). Additionally, Sceneay and colleagues were able to
demonstrate that bone marrow cells cultured with IL-6 and GM-CSF results in the
generation of MDSCs that are phenotypically and functionally similar to MDSCs from
tumor bearing mice (Sceneay et al., 2018). Furthermore, vascular endothelial growth
factor (VEGF) expression is frequently increased in hypoxic tumor environments and
VEGF has been shown to be a chemoattractant for MDSCs (Gabrilovich et al., 1996;
Kusmartsev et al., 2014). Pre-clinical studies using mice have demonstrated that a variety
of pro-inflammatory signals drive MDSCs accumulation.
IL-6 and IL-1β are two pro-inflammatory cytokines that have frequently been
implicated in MDSC generation. MDSCs may not express the IL-1R, however,
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overexpression of IL-1β in 4T1 tumors decreased survival time and elevated levels of
MDSCs in tumor bearing mice (Bunt et al., 2006). This suggests there is a relationship
between IL-1β and IL-6 signaling in the generation of MDSCs. For instance,
administering IL-6 in IL-1R-deficient mice harboring 4T1 tumors restores MDSCs and
hastens tumor progression (Bunt et al., 2007) suggesting that IL-6 is downstream of IL1β. Additionally, TNF-α, another proinflammatory cytokine commonly found in the
tumor microenvironment, also promotes the accumulation of MDSCs. Pharmacological
inhibition of TNF-α has been shown to facilitate the differentiation of MDSCs into
dendritic cells and macrophages (Sade-Feldman et al., 2013). Collectively, the results of
these studies suggest that chronic inflammatory signals such as IL-1β and TNF-α may
stimulate the release of IL-6 and GM-CSF from other cell types such as macrophages,
which in turn promotes MDSC generation in the bone marrow.
Myeloid-Derived Suppressor Cells:
Mechanisms of Immune
Suppression
Multiple mechanisms are involved in immune suppression by MDSCs. The
primary mechanisms that have been described involve the depletion of key nutrients
involved in T-cell proliferation and the generation of oxidative stress that affects T-cell
trafficking and activation. Overexpression and/or production of arginase 1 (Arg1)
(Highfill et al., 2010), nitric oxide synthase (Arina & Bronte, 2015), hydrogen peroxide,
superoxide (Corzo et al., 2009), and peroxynitrite (Nagaraj et al., 2007) are some of the
key phenotypical and functional characteristics of MDSCs. The mechanisms listed above
are most frequently studied in peripheral lymphoid organs, as there are technical
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challenges with isolating MDSCs from tumors at a high enough frequency that allows for
functional assessment (Kumar, Patel, Tcyganov, & Gabrilovich, 2016).
Arg1 catalyzes the following reaction: L-arginine + H2O → ornithine + urea and
the overexpression of Arg1 in MDSCs leads to significant depletion of L-arginine (Atkins
et al., 2009; Raber, Ochoa, & Rodríguez, 2012; Rodriguez et al., 2005). L-arginine is an
amino acid used in the biosynthesis of proteins and has been shown to be important for Tcell proliferation and function. For example, Zea et al. demonstrated that T-cells activated
in vitro in the absence of L-arginine had decreased expression of CD3, an important coreceptor in the T-cell receptor (TCR) complex that generates activation signals in T-cells
(Zea et al., 2004). Additionally, T-cells cultured in the absence of L-arginine are arrested
in the G0-G1 phase of the cell cycle, while cells cultured with L-arginine progress
through to the M phase (Rodriguez, Quiceno, & Ochoa, 2007). Therefore, the
overexpression of Arg1 in MDSCs and depletion of L-arginine presents a major barrier to
T-cell proliferation and activation in tumor bearing individuals.
MDSCs generate a significant amount of oxidative stress through their production
of reactive oxygen species (ROS). This is accomplished primarily by an increased
expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase which
catalyzes the production of a superoxide free radical by transferring an electron to oxygen
from NADPH. Increased expression of NADPH oxidase in MDSCs causes large amounts
of ROS to be released, which inhibits activation of T-cells (Corzo et al., 2009; Huang et
al., 2013). Specifically, when MDSCs are in close proximity to T-cells, nitration of the
TCR and/or CD8 receptor alters the conformation of the protein resulting in significantly
reduced antigen recognition (Nagaraj et al., 2007). In summary, depletion of key nutrients
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and nitration of the TCR represent two of the primary mechanisms by which MDSCs
exert their immunosuppressive effects on adaptive immune cells.
Myeloid-Derived Suppressor Cells
and Metastasis
Evidence exists for a role of MDSCs in the majority, if not all, steps that lead to
the development of metastatic disease. MDSCs employ numerous mechanisms that
facilitate invasion of tumor cells into surrounding tissue and seeding in distant organs.
Clinically, high levels of MDSCs have been correlated with an increase in metastasis in
the lymph nodes of breast cancer patients (Yu, Wang, Yan, Li, & Ren, 2013).
Additionally, MDSCs are correlated with increased metastasis in several other cancer
types including non-small cell lung cancer (Huang et al., 2013) and melanoma (Weide et
al., 2014). Consequently, there has been increasing interest in uncovering the
mechanisms utilized by MDSCs that promote metastasis.
The current research suggests that MDSCs can be recruited to the pre-metastatic
site before tumor cells and facilitate tumor seeding by creating an immunosuppressive
environment. Additionally, MDSCs contribute to tumor invasion by promoting
neovascularization, degradation of the extracellular matrix (ECM), and may even be
involved in the epithelial-mesenchymal transition (EMT) (Condamine, Ramachandran,
Youn, & Gabrilovich, 2014; Safarzadeh, Orangi, Mohammadi, Babaie, & Baradaran,
2018). For example, the chemokines CXCL1, CXCL2, and CXCL5 recruit MDSCs to the
pre-metastatic site and enhance the survival of tumor cells when they arrive by creating
an immunosuppressive environment (Acharyya et al., 2012; Connolly et al., 2009; Toh et
al., 2011). This process represents a paracrine signaling loop between tumor cells and
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MDSCs that enhances tumor seeding in distant organs through the formation of a premetastatic niche.
Neovascularization is important for tumor progression and metastatic
dissemination. Naturally, MDSCs appear to be involved in this process. For instance,
rapid tumor growth results in hypoxia and up-regulation of proangiogenic factors that
enhance MDSC recruitment to the tumor microenvironment via hypoxia inducible factor1α (HIF-1α) (Noman et al., 2014; Qian et al., 2019). Also, MDSCs secrete matrix
metalloproteinases (MMP) that degrade the ECM and increase bioavailability of VEGF
to stimulate blood vessel formation in the tumor (Safarzadeh et al., 2018). Further, Shen
and colleagues (2014) showed that activated MDSCs secrete VEGF which contributes to
the formation of new blood vessels (Shen, Wang, He, Wang, & Zheng, 2014). In general,
these data suggest that MDSCs play a role in the neovascularization of solid tumors
through the production of various pro-angiogenic factors and degradation of the ECM.
Finally, it has been shown that MDSCs play a role in EMT, a critical step in
tumor invasion and metastasis. EMT represents a loss of cell-cell adhesion and
downregulation of E-cadherin which allows for invasion into the basement membrane
and intravasation into the blood stream. In some cases, tumor cells appear to acquire this
motile phenotype through various chemical signals rather than selective, random
mutations. For example, Toh et al. (2011) demonstrated that purified MDSCs induce
EMT in cancer cells through the secretion of transforming growth factor β (TGF-β),
epidermal growth factor (EGF), and hepatocyte growth factor (HGF) (Toh et al., 2011).
Additionally, recruitment of MDSCs can lead to the activation of EMT-related
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transcription factors such as nuclear factor-B (NF-B) and Snail through the secretion
of high mobility group protein 1 (HMGB-1) (Simpson, Templeton, & Cross, 2012).
Aerobic Exercise and Cancer
Significant epidemiological data exists suggesting that physical activity reduces
the risk for developing cancer. The overall risk of cancer may be reduced by 7% in
individuals who meet the current WHO recommendations for physical activity, which is
150 min/week of MVPA or 10 MET-hours/week. Breast cancer seems to be particularly
responsive to physical activity as both premenopausal and postmenopausal women who
are physically active have a relative risk (RR) of 0.79 and 0.89 respectively (Liu et al.,
2016). The benefits of regular physical activity also show a dose-dependent response.
That is, increased amounts of exercise above the minimum recommended amount by the
WHO show increased protection against the development of cancer (Liu et al., 2011;
Ruiz-Casado et al., 2017). Cancer risk decreases by 1% for every additional 20 METhours/week above 20 MET-hours/week (Liu et al., 2016). Additionally, risk of mortality
due to breast cancer is significantly lower in physically active individuals. When
comparing the highest vs. lowest levels of PA, RR of breast cancer mortality is 0.77 for
pre-diagnosis PA and 0.72 for post-diagnosis PA (Schmid & Leitzmann, 2014). Current
mechanisms that may explain the protection of exercise on cancer development and
mortality include a combination of reduced systemic cancer risk factors and accumulation
of anticancer components following acute bouts of exercise.
Effects of Exercise on Tumorigenesis
It is now well established that physical inactivity is a major risk factor for the
development of cancer and mortality due to cancer. As such, several studies have
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investigated the effects of exercise on tumorigenesis in pre-clinical animal models.
Although differences exist between tumor types depending on the tissue of origin, most
solid tumors utilize oncogenic pathways that allow for overproduction of inflammatory
signals, immune system evasion, promotion of angiogenesis, and apoptosis resistance.
Exercise has the potential to affect the variables listed above and has consequently
become the primary focus of current research.
Recently, Pedersen and colleagues showed that voluntary wheel running in mice
reduced tumor growth by as much as 60% across five different tumor models (Pedersen
et al., 2016). This reduction in tumor growth was associated with an epinephrine and IL6-dependent mobilization of NK cells to the tumor microenvironment as blockade of
these signaling pathways negated the effects of exercise on tumor growth. In agreement
with these results, Betof et al. demonstrated that wheel running in Balb/c mice bearing
4T1 tumors significantly reduced tumor growth (Betof et al., 2015). Exercise led to an
increase in tumor cell apoptosis, improved blood vessel maturity, and reduced hypoxia in
these animals. Additionally, Buss and Dachs (2018) showed that voluntary exercise can
decrease tumor hypoxia, which led to a decrease in tumor growth (Buss & Dachs, 2018).
Further, wheel running and treadmill training in mice can reduce intratumoral IL-6 and
VEGF (Amani Shalamzari et al., 2014), increase TNF-α in tumor tissue (Molanouri
Shamsi et al., 2019), and slow tumor growth in a distance-dependent manner (Goh et al.,
2014). In summary, exercise in tumor bearing mice can promote blood vessel maturation
that leads to reductions in intratumoral hypoxia and facilitates infiltration of cytotoxic
immune cells. Additionally, proinflammatory cytokines that have been implicated in the
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recruitment of pro-tumor immune cells may be reduced in the tumor which would
improve immune detection by cytotoxic immune cells.
Effects of Exercise on Inflammation
As described above, tumor-associated inflammation drives cancer progression
through the recruitment of immunosuppressive MDSCs that allow for evasion of immune
surveillance. Pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α have been
shown to regulate MDSC recruitment from the bone marrow. Additionally, CRP is an
acute phase protein released in response to IL-6 and TNF-α that is associated with poorer
prognosis in breast cancer patients (Allin, Nordestgaard, Flyger, & Bojesen, 2011).
Exercise has shown to affect these signaling pathways, and thus has the potential to
temper tumor-induced immune suppression. Various studies have examined the effects of
exercise training on systemic inflammatory signals with both chronic and acute exercise.
Systemic CRP is one of the most frequently measured inflammatory markers
following exercise training. Chronic exercise interventions have been shown to
significantly decrease systemic CRP levels following training (Fairey et al., 2005;
Friedenreich et al., 2012). Additionally, highly trained individuals present with low levels
of circulating CRP compared to sedentary controls. For example, Tomaszewski and
colleagues (2003) showed that CRP concentrations in male ultramarathon runners were
less than half that of controls (Tomaszewski et al., 2003). Systemic decreases in CRP
levels appear to be the most prominent when the exercise intervention exceeds 4 months
(Campbell et al., 2009; Dethlefsen et al., 2017), providing evidence for the importance of
lifelong physical activity for cancer prevention. There is limited data examining CRP
levels in breast cancer patients and the majority of studies show no effect on systemic
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CRP following exercise intervention (Gómez et al., 2011; Guinan et al., 2013; Rogers et
al., 2013). It should be noted that many of these studies involved only 8-12 weeks of
exercise. However, a recent study demonstrated that in a population of cancer survivors
engaged in exercise-based rehabilitation, those with low plasma CRP concentrations had
a significantly higher levels of cardiorespiratory fitness compared to those with
moderate/high concentrations of plasma CRP (Christensen et al., 2019).
The effects of chronic exercise on levels of IL-6 and TNF-α are much more
varied. Some studies have shown a significant decrease in IL-6 and TNF-α (Balducci et
al., 2010; Kullo, Khaleghi, & Hensrud, 2006; Shanely et al., 2013) while others show no
effect of exercise (Friedenreich et al., 2012; Libardi, De Souza, Cavaglieri, Madruga, &
Chacon-Mikahil, 2012). Further, a meta-analysis of over 150 studies showed that IL-6
and TNF-α concentrations were unchanged with exercise in individuals without a cancer
diagnosis (Lin et al., 2015). Similarly, a meta-analysis of exercise interventions in breast
cancer patients showed no effect of training on IL-6 and TNF-α levels (Kang et al.,
2017). Again, most of these interventions were of a relatively short duration suggesting
that the most pronounced effects of chronic exercise on systemic inflammatory markers
require longer periods of training.
Many studies have investigated the chronic effects of exercise on systemic
inflammation and cancer risk factors, yet the acute effects of exercise on tumor biology
remain a somewhat neglected area of research. However, several preclinical studies have
shown that exercise-conditioned serum following acute exercise can directly inhibit the
growth of cancer cells in vitro (Dethlefsen et al., 2016; Gannon, Vaughan, Garcia-Smith,
Bisoffi, & Trujillo, 2015; Hojman, Dethlefsen, & Pedersen, 2010). Also, It is now well
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established that IL-6 significantly increases following acute bouts of exercise evident by
a >10 fold increase following prolonged bouts of PA (Pedersen & Febbraio, 2012).
Unlike IL-6 secreted from immune cells in response to pro-inflammatory signals such as
TNF-α, this is generally considered an anti-inflammatory response due to the acute
induction of anti-inflammatory cytokines. For example, infusion of IL-6 does not
increase levels of the pro-inflammatory cytokine TNF-α while enhancing the plasma
levels of the anti-inflammatory cytokines IL-1ra and IL-10 (Steensberg et al., 2003).
Additionally, Nieman et al. (2006) reported that there is a 2.7-fold increase in blood
leukocyte IL-10 mRNA and a 2.2-fold increase in blood leukocyte IL-1ra mRNA 1-hour
post-exercise (Nieman et al., 2006). Further, this anti-inflammatory milieu is maintained
for several hours following exercise (Mendham, Duffield, Marino, & Coutts, 2015).
These data suggest that both long-term training and the accumulation of repeated bouts of
acute exercise are important for the anti-inflammatory effects of exercise. The
accumulated surge of anti-inflammatory cytokines following acute exercise may also
directly counteract pro-inflammatory signals that are frequently associated with MDSC
induction and tumor progression such as IL-1β and pro-inflammatory IL-6.
Effects of Exercise on Metastasis
Metastatic disease is the primary cause of cancer-related deaths. As described
above, regular physical activity can reduce the risk for mortality due to cancer by as
much as 20% (Schmid & Leitzmann, 2014). Therefore, it has been hypothesized that
exercise may decrease the dissemination of tumor cells to distant organs. Indeed, there
have been several studies investigating the effects of exercise on metastasis, however,
methodological differences make it difficult to definitively answer this question. For
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example, many studies use intravenous (tail-vein) injection of tumor cells (HoffmannGoetz, MacNeil, & Arumugam, 1994; Jadeski & Hoffman-Goetz, 1996; MacNeil &
Hoffman-Goetz, 1993; Pedersen et al., 2016), while others investigate metastasis arising
from the primary tumor (Dethlefsen et al., 2016; Gershbein, Benuck, & Shurrager, 1974).
Intravenous injection of tumor cells allows for evaluation of the ability of circulating
tumor cells to survive and colonize in an organ, however it does not allow for
investigation of the early steps in the metastatic cascade. Thus, the most appropriate
model of metastasis is orthotopic primary tumors that spontaneously metastasize to
distant organs.
Concerning the effects of exercise on metastasis, it is difficult to make meaningful
comparisons between studies due to differences in tumor models and exercise protocols.
In models of metastasis that arise from primary tumors, most studies show no effect of
exercise. For instance, Jones et al. (2012) used voluntary wheel running in mice
orthotopically injected with C-1 prostate cancer cells and showed a non-significant
decrease (34%) in the number of metastatic lesions. In support of these results, Yan and
colleagues (2011) demonstrated that there was a non-significant trend toward a decrease
in tumor metastasis with voluntary wheel running after surgical resection of Lewis lung
carcinoma tumors (Yan & Demars, 2011). Conversely, a recent study showed that
pulmonary metastasis was increased with voluntary wheel running in the 4T1 tumor
model (Smeda et al., 2017). Further, studies using intravenous injection of tumor cells
have shown that exercise can decrease radioactivity in the lungs from radiolabeled tumor
cells (Hoffmann-Goetz, MacNeil, & Arumugam, 1994), decrease tumor cell retention in
the lungs (Jadeski & Hoffman-Goetz, 1996), and lower the number of B16 tumors in the
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lungs (Pedersen et al., 2016). These data suggest that exercise has minimal effects on
tumor metastasis, however differences in training modality, tumor model, and
quantification of metastases make it difficult to make definitive conclusions. Therefore,
more studies using orthotopic tumor models are needed.
Summary
Breast cancer incidence remains relatively unchanged and is largely attributed to
worldwide increases in lifespan, physical inactivity and obesity. Consequently, a
significant number of people are living with breast cancer. While a large body of
evidence suggests that regular PA can reduce cancer risk and mortality, the biological
mechanisms explaining this relationship remain unclear. Tumor progression is driven in
part by chronic inflammation that results in the generation of pro-tumor MDSCs. MDSCs
inhibit antitumor immunity, promote metastasis, and reduce the efficacy of
immunotherapy. Pre-clinical studies show that exercise has the potential to slow tumor
growth by normalizing tumor vasculature, which reduces intratumoral hypoxia and
facilitates infiltration of cytotoxic immune cells. Additionally, exercise can reduce
systemic inflammation and promote an anti-inflammatory phenotype following acute
exercise. The anti-inflammatory effects of exercise have the potential to directly oppose
signals that have been implicated in MDSC generation, yet no studies have investigated
the effects of exercise on MDSC-related tumor progression.
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CHAPTER III
METHODS
Experimental Design
This study utilized endurance training to examine the effects of exercise on
MDSC-related tumor progression and metastasis in an orthotopic mouse model of breast
cancer. The primary purpose of this study was to determine if exercise temporally delays
the onset of MDSC accumulation in the blood, spleen, and tumor of tumor-bearing mice.
A secondary purpose of this study was to examine the effects of exercise on MDSC
function by measuring the suppressive quality of these cells in vitro. The final purpose of
this study was to determine the effects of exercise on lung metastasis. These exercise
effects were evaluated using a 10-week endurance exercise voluntary wheel running
protocol. On the 6th week of the training protocol, animals were inoculated with 1x104
4T1 tumor cells in the dorsal mammary fat pad and then continued to train for an
additional 4 weeks. Subgroups were sacrificed at varying time points following tumor
inoculation to examine the time course of MDSC accumulation. Figure 1 outlines the
experimental design of this study.
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Figure 1. Experimental Design. WR, wheel run; SED, sedentary; TUM, tumor.
WR+TUM groups, n = 10 per time point. SED+TUM groups, n = 10 per time point.
Animals and Animal Care
Female Balb/c mice (n = 80) were housed individually in a temperature-controlled
facility with a 12:12 hour light-dark schedule. Additionally, female age-matched nontumor control mice (n = 20) were used to harvest naïve splenocytes for T-cell suppression
assays. Mice were given standard chow and distilled water ad libitum. All procedures
were approved by the University of Northern Colorado’s Institutional Animal Care and
Use Committee (IACUC) and were in compliance with the Animal Welfare Act
guidelines.
Exercise Training Protocol
Mice, 8 weeks of age, were randomly assigned to either a wheel run (WR+TUM)
or sedentary (SED+TUM) group on day one of the exercise intervention. SED+TUM was
restricted to normal cage activity for the duration of the study. WR+TUM animals were
given 24-hour access to commercially available running wheels (11.5 cm by diameter)
(MiniMitter; Bend, OR) for the duration of the study. Running distance was monitored
using a Vital View data acquisition system (MiniMitter; Bend, OR).
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Cell Culture, Tumor Inoculation,
and Measurement
The 4T1 mouse mammary carcinoma (ATCC, Manassas, VA) cell line was used
to establish orthotopic tumors in the mammary gland. Cells were grown in Roswell Park
Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS)
and maintained in a humidified incubator with 5% CO2. Cell growth medium was
replaced every two to three days.
On week 6 of the study, animals were sedated with isoflurane and inoculated
subcutaneously with 1x104 4T1 cells suspended in 100 µl of PBS in the fourth mammary
gland on the right side using a 25-gauge syringe needle. Mice were the most active from
8:00 PM – 8:00 AM during this study. Therefore, to ensure that injections were
performed during a period of reduced activity, all tumor inoculations occurred between
11:00 AM and 1:00 PM. Following tumor inoculation, SED+TUM and WR+TUM were
randomly subdivided into different time point groups: 16 days (n = 10), 20 days (n = 10),
24 days (n = 10), or 28 days (n =10). Previous unpublished data in our lab demonstrated
that mice injected with 1x104 4T1 cells develop palpable tumors after 8 days on average.
Also, these tumors become measurable with digital calipers after 14 days on average.
Although tumors are present well before the 16-day time point, it is unlikely that enough
cells could be harvested for flow cytometric analysis. Thus, the earliest time point of 16
days was chosen. Additionally, pilot data from our lab indicate that MDSCs are not
present in the tumor or peripheral lymphoid organs by 12 days post-tumor injection,
making functional analysis of these cells impossible. For additional time-points of
sacrifice, 4-day intervals were chosen because previous data have shown that 4T1 tumors
grow at a relatively linear rate when measured every 3-5 days (Bunt et al., 2007).
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Subgroups of mice were sacrificed at the specified time points post-injection. Body
condition, and tumor volume was monitored three times per week for the duration of the
study. Tumor length and width was measured using digital calipers. These measurements
were used to estimate tumor volume using the following formula: π/6 × width × length2,
where length equals the largest diameter, and width was measured 90° from length.
Flow Cytometry
Tissue Preparation and Analysis
Spleen, blood, and tumor samples were harvested and prepared for flow
cytometry. Spleens were mechanically dissociated using the frosted end of two
microscope slides and filtered through a 100 µm cell strainer. Blood samples were
collected via cardiac puncture into a syringe containing 0.1 mL heparin. Tumors were
excised and mechanically homogenized using a cell dissociation sieve tissue grinder
(Sigma Aldrich), then enzymatically digested in type IV collagenase (2 mg/mL) and
DNase (100 µg/mL) for 45 minutes at 37°C on a platform rocker. Following digestion,
tumor samples were filtered through a 100 µm cell strainer. Single cell suspensions of
splenocytes, tumor, and peripheral blood were cleared of red blood cells (RBC) by
incubating in ammonium-chloride-potassium lysis buffer for 3 minutes at room
temperature. Fc receptors were blocked by incubating samples on ice for 10 minutes in
anti-mouse CD16/32 antibody (BioLegend). Cells were then resuspended in antibody
solution containing fluorochrome-conjugated monoclonal antibody against CD11b, Ly6G, Ly-6C, or the appropriate isotype control (BioLegend). Samples were incubated on
ice, in the dark, for 35 minutes and analyzed on an Attune NxT flow cytometer. Initial
forward scatter/side scatter gating was used to exclude debris and doublets from analysis.
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Unstained and isotype controls were used to exclude background fluorescence and ensure
there is no evidence of non-specific binding. Proportions of MDSCs were quantified in
the blood, spleen, and tumor and were reported as total MDSCs as a percentage of the
total cells in the sample. A representative example of the gating strategy used to identify
MDSCs is provided in Appendix B.
Myeloid-Derived Suppressor Cell
Sorting Using Fluorescence
Activated Cell Sorting
PMN-MDSCs and M-MDSCs were purified from the spleens of tumor bearing
mice for functional assessment using fluorescence activated cell sorting (FACS). Single
cell suspensions of splenocytes were cleared of red blood cells and stained with zombie
violet viability dye (BioLegend) for 15 min according to manufacturer recommendations.
Next, cells were stained for CD11b, Ly-6G, and Ly-6C as described above. Gates were
established to identify zombie violet negative (viable) cells, then CD11b+Ly6G+Ly6Clo
and CD11b+Ly6G-Ly6Chi cells for sorting. These subpopulations of MDSCs were pooled
and sorted into the same 15 mL conical containing complete RPMI (cRPMI)
supplemented with 20% FBS using a SH800S cell sorter. After sorting, cells were
centrifuged for 7 minutes at 300g. The cell pellet was resuspended in cRPMI growth
medium at a concentration of 1x106/mL and set aside.
T-cell Suppression Assay
Antibody Coating of Microwell Plates
Anti-CD3 antibody was prepared in sterile PBS (5 µg/mL) and 50 µL was
dispensed into each experimental well of a 96-well flat-bottom tissue culture plate. Fifty
µL of sterile PBS was added to unstimulated control wells. The plate was tightly covered
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with Parafilm and incubated for 2 hours at 37oC. Before adding cells, antibody solution
was removed, and each well was washed 2 times with sterile PBS.
Addition of Cells
All samples used for the T-cell suppression assay were handled under sterile
conditions. Splenocytes were harvested from a naïve female Balb/c mouse, 12-15 weeks
of age, and cleared of red blood cells as described above. The cell suspension was
resuspended in cRPMI at a concentration of 2x106/mL and centrifuged for 7 minutes at
300g. The cell pellet was then resuspended in CellTrace Violet (1:1000) and incubated at
37oC for 20 minutes protected from light. CellTrace Violet was quenched by adding
cRPMI and incubating cells for an additional 5 minutes at 37oC. Cells were pelleted and
resuspended in cRPMI. Next, 100 µL of the splenocyte cell suspension (2x105 total cells)
was added to each well. One hundred µL of the MDSC suspension (1x105 total cells) was
added to each experimental well for a 2:1 splenocyte to suppressor ratio. To account for
higher cell numbers and added competition for resources in the experimental wells, 3x105
splenocytes were added to control wells to equal the total number of cells in experimental
wells. One hundred µL of cRPMI was added to unstimulated control and stimulated
control wells for a final volume of 200 µL/well. Next, soluble anti-CD28 (2 µg/mL)
antibody was added to each stimulated well. Finally, samples were incubated at 37oC for
72 hours and analyzed on an Attune NxT flow cytometer.
Figure 2 outlines an example of the setup of control and experimental wells.
Representative results from dye dilution analysis are presented in Figure 3. The peak
farthest to the right, which has the highest fluorescence of CellTrace Violet, represents
cells that have not divided. Peaks to the left represent T-cells that have divided one or

27

more times. CellTrace fluorescence decreases (becomes more dilute) with multiple cell
divisions. Using the FCS express software, a proliferation index can be calculated from
this histogram which is the average number of divisions of responding cells. The
proliferation index should be lower in splenocytes co-cultured with MDSCs.

Figure 2. T-cell suppression assay design. Theoretical setup of a culture dish for
functional assessment of MDSCs from an individual animal run in duplicate. All
splenocytes were labeled with CellTrace Violet for detection of proliferation via dye
dilution. Stimulated wells were coated with anti-CD3 antibody and soluble anti-CD28
antibody for activation of CD3+CD28+ T-cells. MDSCs were isolated from individual
tumor-bearing mice and added to experimental wells at a ratio of 1:0.5 splenocyte to
MDSC.
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Figure 3. Detection of cell division by dye dilution. Cells were stained with CellTrace
Violet and stimulated with CD3 antibody. The peak outlined in black are cells that have
not divided (unstimulated controls). Violet peaks represent successive generations of
cells.

Lung Metastasis
An incision was made along the midline of the abdomen through the ribcage and
up toward the salivary glands. The trachea was identified and elevated by threading a
pipette tip underneath. Using a 27-G syringe needle, India Ink (10% India Ink and 0.1%
ammonium hydroxide) was injected into the lungs via the trachea until resistance was
felt. The trachea was cut, and the lungs were removed. Lungs were rinsed briefly with
deionized water and transferred to a glass vial containing 3 mL of Fekete’s solution (50%
ethanol, 6% formaldehyde, 3% glacial acetic acid). After at least 10 minutes, tumor
nodules were visualized as white dots on black lungs (Figure 8B). Lungs were transferred
to a dish and individual white dots were counted as a single metastatic tumor nodule
(Paschall & Liu, 2016). Metastatic nodules were manually counted on the surface of both
the right and left lung. Each animal has a total surface metastatic nodule count, and an
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average surface nodule count was obtained for each group. Group averages were
compared to determine the effects of exercise on the number of metastatic lung nodules.
Statistical Analysis

All data are presented as means ± standard error of the mean. For tissue-resident
MDSC proportions, a student’s t test was used to identify group differences for the
number of MDSCs in spleen, blood or tumor samples. For tumor volume, tumor mass,
and metastatic lung nodules, student’s t tests were performed for the specified time points
to determine group differences. If variances were significantly different, a t test with
Welch’s correction was used. For T-cell proliferation, repeated measures ANOVA was
used to identify differences between stimulated controls, and co-cultures containing
MDSCs harvested from SED+TUM or EX+TUM. P-values with p < 0.05 were
considered significant.
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CHAPTER IV
RESULTS
General Observations
A total of 7 animals (SED+TUM day 16, 20, 24, and 28, n = 1/timepoint;
WR+TUM day 16, 24, and 28, n = 1/timepoint) were euthanized early and excluded from
analysis due to poor body condition as a result of tumor growth during this study. No
differences were observed between groups for initial body mass or final body mass over
the course of the study (Figure 4). Additionally, no differences were observed in running
distance between different timepoint groups (Figure 5). This is expected as mice tend to
run more during the first weeks of being housed in a wheel running cage and
progressively decrease their running volume each subsequent week, resulting in only
slightly higher post-injection distances in the 24 and 28 day groups (Turner, Kleeberger,
& Lightfoot, 2005).
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Figure 4. Body Mass. Day 0 represents initial body mass for all animals included in the
study (n = 40/group). Day 16-28 points represents final body mass at the corresponding
timepoint at the time of sacrifice (n = 9-10/group).
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Figure 5. Running distance in WR+TUM animals. (A) Pre-tumor running distance, (B)
post-tumor cell injection, and (C) total running distance at the specified timepoints.
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Myeloid-Derived Suppressor Cell Accumulation
and Tumor Progression
Spleen, blood, and tumor samples were analyzed in tumor-bearing mice at the
indicated time points to determine the effects of physical activity on MDSC
accumulation. At day 16, a marked increase in the number of these cells was observed in
tumor bearing animals. In WR+TUM animals, MDSCs in the spleen were significantly (p
< 0.05) lower than SED+TUM at day 16 (23.0 ± 10.0% vs. 33.0 ± 5.2%) and day 20
(24.3 ± 5.1% vs. 33.9 ± 8.0%) (Figure 6A). The effect of exercise on MDSC
accumulation in the spleen was lost by day 24 and 28 as no differences were observed
between groups. Additionally, at day 16, circulating MDSCs in the blood were
significantly lower (p < 0.05) in WR+TUM (14.7 ± 8.5%) when compared to SED+TUM
(23.2 ± 7.1%) (Figure 6B). Interestingly, it appears that MDSCs do not begin to infiltrate
4T1 tumors until the later stages of progression. While MDSC populations increased in
the spleen and blood by day 16, MDSC levels in the tumor remained relatively low until
day 28. A recent study showed that a combination of physical activity and energy
restriction reduced total MDSCs in the tumor microenvironment (TME) 35 days posttumor implantation by about 15% (Turbitt et al., 2019). In comparison, we observed a
non-significant (p = 0.08) 24% decrease in MDSCs in the TME of WR+TUM (17.2 ±
5.3%) when compared to SED+TUM (23.2 ± 8.7%) at day 28 independent of energy
restriction (Figure 6C). While the delay in accumulation of MDSCs did not translate to
smaller tumors at any timepoint (Figure 7), there was a non-significant 62% and 26%
reduction in metastatic lung nodules in WR+TUM at days 24 and 28, respectively (Figure
8A). Spleen mass progressively increased as tumor size increased, and no differences
were observed with physical activity (Figure 9).
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Figure 6. MDSC accumulation. (A) Total accumulation of MDSCs in the spleen (B)
blood, and (C) tumor at the specified time-points post-4T1 cell injection. Means ± SEM.
*p < 0.05 vs. WR+TUM. For tissue MDSCs, a student’s t test was used to compare
groups.
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Figure 7. Tumor mass. Progression of tumor mass over the course of the study. Means ±
SEM. A student’s t test was used to compare groups at each respective timepoint post4T1 cell injection.

Figure 8. Metastatic lung nodules. (A) Progression of the absolute number of metastatic
lung nodules over the course of the study. (B) Representative lung samples from day 28
animals showing visualization of white nodules on black lungs. Means ± SEM. A
student’s t test was used to compare groups at each respective timepoint post-4T1 cell
injection.
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Figure 9. Spleen mass. Progression of spleen mass over the course of the study. Means ±
SEM. A student’s t test was used to compare groups at each respective timepoint post4T1 cell injection.
T-cell Suppression Assay
MDSCs were identified and purified from the spleen using FACS. Representative
samples from the spleen of an individual WR+TUM animal at day 28 before sorting and
after sorting are presented in Figure 10. Average purity of all sorted samples was >80%,
which is within the normal expected range when using this method (Solito et al., 2019).
Pathological activation of MDSCs has been described previously as a gradual process
that is related to tumor progression (Gabrilovich, 2018). The results presented here
support this idea as MDSCs purified from tumor bearing mice did not become
significantly suppressive toward T-cell proliferation until day 28. CD3+CD4+ T-cell
proliferation index in SED+TUM MDSC co-cultures (3.19 ± 0.47) was significantly
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lower (p < 0.05) than stimulated control samples (5.30 ± 0.53) (Figure 11A). In
comparison, CD3+CD4+ cell proliferation index in WR+TUM MDSC co-cultures (5.05 ±
0.59) was not significantly suppressed suggesting that endurance exercise delayed the
acquisition of suppressive function by MDSCs. At all timepoints, CD3+CD8+ T-cell
proliferation was not significantly suppressed in either group (Figure 11B). However,
CD3+CD8+ T-cell proliferation in WR+TUM co-cultures (5.54 ± 0.53) at day 24 was
significantly higher (p < 0.05) than stimulated controls (4.04 ± 0.69) suggesting that these
cells were potentially promoting CD3+CD8+ T-cell proliferation.

Figure 10. Gating strategy for MDSC purification using FACS. (A) Spleen sample from
individual day 28 WR+TUM animal before sorting. (B) Post-sort analysis of purified
MDSCs.
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Figure 11. T-cell suppression assay in MDSC co-cultures. (A) CD3+CD4+ T-cell
proliferation in stimulated controls and MDSC co-cultures at the specified timepoint
post-4T1 cell injection. (B) CD3+CD8+ T-cell proliferation in stimulated controls and
MDSC co-cultures at the specified timepoint post-4T1 cell injection. (C) Representative
CD3+CD4+ T-cell proliferation plots in day 28 samples. Median CellTrace violet
fluorescence in unstimulated samples was used to set the starting undivided population
(vertical black line). Splenocytes were stimulated to proliferate using anti-CD3ε and antiCD28 antibody. *p < 0.05 vs. stimulated control. For statistical analysis a repeatedmeasures ANOVA with Tukey’s multiple comparison was used.
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CHAPTER V
DISCUSSION AND CONCLUSIONS
This was one of the first studies to examine the effects of exercise on the timecourse of MDSC accumulation and function in a murine model of metastatic breast
cancer. The hypothesis in response to our first specific aim was partially supported, as the
numbers of MDSCs in WR+TUM were significantly lower in the spleen and blood when
compared to SED+TUM. However, while MDSCs in the tumor of WR+TUM were
trending lower compared to SED+TUM, this difference was not significant (p = 0.08).
The second hypothesis of this study stated that MDSCs from exercising mice would have
a reduced suppressive capacity. This hypothesis was also supported, evidenced by
reduced suppression of T-cells in MDSC co-cultures from WR+TUM. Although there
was a trend toward lower metastatic lung nodules in WR+TUM at day 24 and 28, this
difference was not significant, which resulted in rejection of our third hypothesis.
A growing body of literature suggests that physical activity, both acute and
chronic, can favorably modulate immune function, with beneficial effects that potentially
extend into the prevention and treatment of cancer. Physical activity and exercise is
known to modulate inflammatory signaling, as well as the expansion and recruitment of
both myeloid and lymphoid lineage immune cells (Hojman, 2017). Nearly all leukocyte
populations are mobilized to the blood during acute exercise, and moderate intensity
exercise is known to improve chemotaxis, phagocytosis, and oxidative burst activity in
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neutrophils (Pedersen & Hoffman-Goetz, 2017). MDSCs are immature myeloid cells
routinely associated with a poorer prognosis in several cancer types (Veglia, Perego, &
Gabrilovich, 2018) and pharmacological blockade of MDSCs can slow the growth of
transplantable tumors (Davis et al., 2017; Kumar, Cheng et al., 2016). To date, only one
study has investigated the effects of voluntary wheel running on the accumulation of
MDSCs in a pre-clinical animal model and the present study aimed to determine if
physical activity could improve antitumor immunity by reducing the accumulation of
MDSCs in an orthotopic mouse model of breast cancer. Our data show that voluntary
wheel running significantly delayed the accumulation of MDSCs in the spleen and blood.
Additionally, there was a modest reduction in intratumoral MDSCs, however, these
effects did not translate to smaller tumors by size and weight. Few groups have
investigated the effects of physical activity on metastasis in 4T1 tumor-bearing mice and
here we observed a non-significant 62% and 26% reduction in the number of metastatic
lung nodules at days 24 and 28, respectively. In comparison, a recent study showed that
wheel running in 4T1 tumor-bearing mice increased metastatic burden in the lungs when
mice began running concurrently with tumor injection (Smeda et al., 2017). Turbitt et al.
recently reported that energy restriction preventing weight gain in combination with
voluntary wheel running significantly reduced M- and PMN-MDSCs in the spleen and
tumor which led to a decrease in tumor growth (Turbitt et al., 2019). They also observed
a non-significant decrease in metastatic burden in the lungs of wheel running mice fed ad
libitum. By comparison, we report that physical activity can reduce the numbers of these
cell populations independent of energy restriction. Taken together, these results suggest
that weight management may be important to maximize the beneficial
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immunomodulatory effects of physical activity in tumor-bearing mice. One potential
mechanism explaining these findings is the normalization of tumor vasculature with
physical activity. For example, others have shown that 18 days of wheel running
following implantation of 4T1 tumor cells resulted in improved vessel maturity,
perfusion, and reduced hypoxia in the tumor microenvironment (Betof et al., 2015).
Reductions in hypoxia have been shown to reduce the accumulation of MDSCs in 4T1
tumors, decrease the expression of programmed cell death receptor ligand 1 (PD-L1), and
increase the recruitment of T-cells to the tumor microenvironment (Qian et al., 2019).
A hallmark of MDSCs is the ability to suppress T-cell proliferation. MDSCs
purified from SED+TUM mice appeared to preferentially suppress CD3 +CD4+ T-cell
proliferation while MDSCs from WR+TUM mice did not significantly suppress T-cell
proliferation at 28 days, suggesting that physical activity may help normalize
myelopoiesis and consequently the function of MDSCs. Compared to the findings of
Turbitt et al. where they observed an increased proliferation of CD4+ T-cells harvested
from physically active tumor-bearing mice (Turbitt et al., 2019), we showed that physical
activity may directly alter the ability of MDSCs to suppress naïve T-cells evidenced by
reduced T-cell suppression in MDSC co-cultures at day 28. Additionally, CD3+CD8+ Tcell proliferation was significantly higher than controls in WR+TUM MDSC co-cultures
at day 24 suggesting that these cells were promoting cytotoxic T-cell proliferation.
MDSCs are often described as immature immune cells that are highly plastic depending
on the context of the microenvironment. It is possible that the anti-inflammatory effects
of physical activity may help normalize the aberrant myelopoiesis associated with
accumulation and activation of MDSCs.
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Exercise had no effect on the rate of tumor progression in our study. Mixed
results have been reported in the literature, with some studies in 4T1 tumor bearing mice
showing that voluntary wheel running can slow the growth of 4T1 tumors (Betof et al.,
2015; Goh et al., 2014; Hagar et al., 2019), while other recent reports show that wheel
running alone had no effect on tumor growth in 4T1 tumor-bearing mice (Smeda et al.,
2017; Turbitt et al., 2019). We propose that pre-training is important for the observed
antitumor effects of physical activity which may be related to the running habits of
rodents. Mice run the highest volumes the first several weeks after being housed with a
running wheel and progressively decrease their running volume during subsequent weeks
(Turner et al., 2005). Adaptations that promote an anti-inflammatory environment and
progression toward more low-moderate running intensity may be important for the
anticancer effects observed in pre-training models. In comparison, animals that begin
running on the day of tumor inoculation may run at a volume and intensity that is
ultimately immunosuppressive, negating any potential anticancer effects.
Immune checkpoints regulate the immune system by promoting self-tolerance and
preventing autoimmunity. Tumors are known to co-opt these immune checkpoint
pathways to evade immune surveillance by T-cells specific for tumor antigens.
Checkpoint inhibitor immunotherapy targets these immune checkpoints by blocking the
interaction between checkpoint proteins that inactivate tumor-specific T-cells (Pardoll,
2012). High levels of circulating MDSCs have been used as a predictor of the clinical
response to immunotherapy with higher MDSCs being associated with treatment failure
(De Henau et al., 2016; Ostrand-Rosenberg & Fenselau, 2018). In patients treated with
the checkpoint inhibitor ipilimumab, low levels of circulating MDSCs were associated
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with increased survival and improved treatment outcomes (Schilling et al., 2016).
Additionally, depletion of MDSCs in pre-clinical mouse models significantly improves
the outcomes of immunotherapy (Iida et al., 2017) and exercise has been shown to
regulate inflammatory signals such as IL-6 and IL-1β that are implicated in MDSC
accumulation (Bunt et al., 2007; Murphy et al., 2011; Pedersen & Hoffman-Goetz, 2017).
Also, human breast cancer survivors who participated in a six month endurance training
intervention had significant reductions in serum levels of systemic inflammatory
cytokines such as TNF-α and IL-6 (Christensen et al., 2019). Further, an acute bout of
exercise has been shown to increase serum concentrations of the anti-inflammatory
cytokines interleukin 10 (IL-10) and interleukin-1 receptor antagonist (IL-1ra) (Petersen
& Pedersen, 2004). Taken together, the anti-inflammatory effects of exercise described
above in both animal models and human subjects have the potential to regulate several of
the mechanisms involved in the accumulation and maintenance of MDSCs, specifically
the IL-1β and IL-6 signaling pathways. However, future work is necessary to determine
whether these factors are underlying mechanisms behind the beneficial effects of physical
activity observed in this study.
Conclusions
The present study investigated the effects of voluntary wheel running on the
temporal accumulation of pro-tumor MDSCs and metastatic burden in a murine model of
breast cancer. Despite a profound uptick in MDSC production in tumor-bearing animals,
voluntary wheel running was able to delay the accumulation of immunosuppressive
MDSCs. Furthermore, MDSCs harvested from physically active mice were less
suppressive toward T-cell proliferation in vitro and enhanced cytotoxic T-cell
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proliferation at day 24 post-tumor injection. Thus, findings from the present study
suggest that physical activity may be a cost-effective way to reduce the severity of
aberrant myelopoiesis that results in the accumulation of pathologically activated
MDSCs, which could potentially improve the efficacy of now common immunotherapies
such as programmed cell death 1 receptor (PD-1)/PD-L1 checkpoint inhibitors.
Limitations
While the 4T1 tumor model has been used extensively to study MDSC biology,
there are some limitations to our design. It is possible that with a higher ratio of MDSCs,
some suppressive effects may be observed at earlier timepoints. However, due to low
numbers of MDSCs at the early timepoints, only a 2:1 splenocyte-to-suppressor ratio was
used. Additionally, different subpopulations of MDSCs exert their immune suppressive
effects using different mechanisms. Again, due to low cell numbers at early timepoints,
especially in the M-MDSC population, both populations were pooled together in this
study making it difficult to determine where the observed effects of physical activity are
occurring. These findings were limited to the 4T1 breast cancer tumor model and future
research into the effects of physical activity on MDSC accumulation in additional tumor
models will help to confirm the results presented here. Experiments using S100A9
knockout mice, which have a reduced capacity to generate MDSCs, would help confirm
that the observed effects in this study were physical activity-dependent. Additional assays
further characterizing the phenotype and function of T-cells are necessary to determine
the effects of physical activity on antitumor immunity. Finally, mice were individually
housed to accurately measure running activity. This may potentially affect immune
function, as mice experience less stress in social groups and have an increased metabolic
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rate to maintain core temperature when housed individually (Krohn, Sørensen, Ottesen, &
Hansen, 2006). All animals in the present study were housed individually to account for
these effects.
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Confirming 4T1 Tumors Stimulate
MDSC Production
Early experiments were conducted to confirm that the 4T1 model stimulates
aberrant myelopoiesis and production of MDSCs in our hands. To confirm this, animals
were assigned to one of four groups (n = 3-10/group); sedentary control (SED), wheel run
control (WR), sedentary tumor (SED+TUM), or wheel run tumor (WR+TUM). Both WR
groups ran for 6 weeks and SED groups were restricted to normal cage activity. After the
6-week pre-training period, both TUM groups were inoculated with 1x104 4T1 cells and
tumors were allowed to grow for 28 days. After 28 days, animals were sacrificed and
MDSCs were analyzed in the spleen and blood. As expected, there was a significant
increase in these cells in the spleen and blood of tumor-bearing animals when compared
to non-tumor controls (Figure 12). Additionally, no differences were observed between
SED and WR controls indicating that physical activity does not alter myelopoiesis in
non-tumor animals, which is why this study excluded non-tumor control animals.

Figure 12. 4T1-dependent MDSC production. MDSCs were analyzed in the spleen and
blood after 28 days of tumor growth. Means ± SEM. **p < 0.01 vs. non-tumor controls.
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Determining Earliest Timepoint for MDSC
Functional Analysis
To determine the earliest timepoint to begin purification and functional analysis
of MDSCs, pilot experiments were performed to determine when an uptick in MDSCs is
observed in tumor-bearing animals. Animals were assigned to either a sedentary tumor
(SED+TUM) or wheel run tumor (WR+TUM) group. After 6 weeks of wheel running, all
animals were inoculated with 4T1 tumor cells and sacrificed 12 days later. While
palpable tumors were present in these animals, MDSCs were relatively undetectable.
MDSCs in the spleen (Figure 13A), blood (Figure 13B), and tumor (Figure 13C) were
less than 5% of the total cells, which is similar to what is observed in non-tumor control
animals (Figure 12). It is likely that these are normal myeloid cells that have not yet been
pathologically activated, thus a later timepoint of 16 days was chosen as the earliest
timepoint for this study.
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Figure 13. Early MDSCs. MDSCs in the (A) spleen, (B) blood, and (C) tumor of tumorbearing animals after 12 days of tumor growth. Means ± SEM.
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APPENDIX B
MYELOID-DERIVED SUPPRESSOR CELL GATING STRATEGY

73

Gating Strategy for Identifying Myeloid-Derived
Suppressor Cells
The cell surface markers CD11b, Ly6C, and Ly6G are the most common markers
used to identify MDSCs in mice. PMN-MDSC are CD11b+Ly6Clo Ly6G+ and M-MDSC
are CD11b+Ly6ChiLy6G-. As described in the methodology, samples were stained with
fluorescent monoclonal antibodies for these markers and run on an Attune NxT flow
cytometer. Data from the flow cytometer were exported and analyzed using FCS express
(De Novo software). The gating strategy to identify and quantify these cells in a
homogenous tissue sample is presented in Figure 14 below. Initial gating is used to
identify cells and exclude debris with a low forward scatter (FSC-A) and low side scatter
(SSC-A). Next, to exclude doublets, or cells that pass through the flow cytometer stuck
together, the singlets gate was included. Single cells appear at a 45-degree angle on a
FSC-A by forward scatter height (FSC-H) plot. After excluding doublets, primary gates
around CD11b positive cells were established and then secondary gates were established
around Ly6C positive or Ly6G positive cells. As described previously, both populations
of MDSCs were combined and reported as total MDSCs in the sample.
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Figure 14. Myeloid-derived suppressor cell gating strategy.
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